VICL (Vical Labs) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John B. Anderson who wrote (194)	4/29/1997 4:41:00 PM
From: Rainforest	of 1972

The cancer work hasn't proven fruitful because it isn't finished. It's too early to say that it doesn't work. The phase I results, particularly the patient who went into remission, were certainly encouraging. Especially considering the fact that these were people with advanced stages of the disease who couldn't be helped by other therapies. I'm puzzled by your reference to "non-viral approaches to gene therapy". It's my understanding that Vical has a patent on the only non-viral approach. Do you know of others? I think it's important to keep in mind that cancer therapy is only one application of Vical's technology. The vaccines being developed by Merck and Pasteur-Merieux (sp?) are equally significant for potential earnings. Certainly it looks as if any payoff is quite a ways down the line. But that picture could change very rapidly. Sure, all of us a kicking ourselves for not putting our money into Microsoft, et. al. I'm sure that my "Ifida" portfolio is just as long as yours. But it's a bit much to say that we're in a roach motel. You can sell your 1000 shares of VICL tomorrow and buy 80 shares of MSFT with the proceeds.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next